scholarly journals A Phase 2 Trial of Bevacizumab and High-dose Interferon Alpha 2B in Metastatic Melanoma

2011 ◽  
Vol 34 (6) ◽  
pp. 509-515 ◽  
Author(s):  
Valerie P. Grignol ◽  
Thomas Olencki ◽  
Kiran Relekar ◽  
Cynthia Taylor ◽  
Amanda Kibler ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Interferon Alpha ◽  
High Dose ◽  
Phase 2 ◽  
Interferon Alpha 2B ◽  
Phase 2 Trial ◽  
High Dose Interferon

Phase II evaluation of tremelimumab (Treme) combined with high-dose interferon alpha-2b (HDI) for metastatic melanoma.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 8524-8524 ◽  
Author(s):  
A. A. Tarhini ◽  
S. J. Moschos ◽  
H. Tawbi ◽  
Y. Shuai ◽  
W. E. Gooding ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Interferon Alpha ◽  
Phase Ii ◽  
High Dose ◽  
Interferon Alpha 2B ◽  
High Dose Interferon

Phase II trial of bevacizumab and high-dose interferon alpha-2b in metastatic melanoma.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 8520-8520 ◽  
Author(s):  
V. P. Grignol ◽  
T. Olencki ◽  
C. Taylor ◽  
A. Kibler ◽  
C. Kefauver ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
Interferon Alpha ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
High Dose ◽  
Interferon Alpha 2B ◽  
High Dose Interferon

scholarly journals Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice

1999 ◽  
Vol 80 (11) ◽  
pp. 1767-1769 ◽  
Author(s):  
A Ravaud ◽  
C Bedane ◽  
L Geoffrois ◽  
T Lesimple ◽  
M Delaunay
Keyword(s):  
Interferon Alpha ◽  
High Dose ◽  
Interferon Alpha 2B ◽  
High Dose Interferon

scholarly journals A phase 2 trial of sequential temozolomide chemotherapy followed by high-dose interleukin 2 immunotherapy for metastatic melanoma

Cancer ◽  
2008 ◽  
Vol 113 (7) ◽  
pp. 1632-1640 ◽  
Author(s):  
Ahmad A. Tarhini ◽  
John M. Kirkwood ◽  
William E. Gooding ◽  
Stergios Moschos ◽  
Sanjiv S. Agarwala
Keyword(s):  
Metastatic Melanoma ◽  
Interleukin 2 ◽  
High Dose ◽  
Phase 2 ◽  
Phase 2 Trial ◽  
Temozolomide Chemotherapy

A phase 2 trial of high-dose Allovectin-7 in patients with advanced metastatic melanoma

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7509-7509 ◽  
Author(s):  
J. Richards ◽  
A. Y. Bedikian ◽  
R. Gonzalez ◽  
M. B. Atkins ◽  
E. D. Whitman ◽  
...  
Keyword(s):  
Metastatic Melanoma ◽  
High Dose ◽  
Phase 2 ◽  
Phase 2 Trial

A pilot study of interferon-alpha-2b dose reduction in melanoma: High dose interferon is not necessary for optimal activation of immune signal transduction.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e20035-e20035
Author(s):  
Kala M. Levine ◽  
Sara E. Martin Del Campo ◽  
Taylor Brooks ◽  
Elizabeth Streaker ◽  
Leslee Sprague ◽  
...  
Keyword(s):  
Signal Transduction ◽  
Pilot Study ◽  
Dose Reduction ◽  
Interferon Alpha ◽  
High Dose ◽  
Interferon Alpha 2B ◽  
High Dose Interferon

scholarly journals TERT copy gain predicts the outcome of high-dose interferon α-2b therapy in acral melanoma

2018 ◽  
Vol Volume 11 ◽  
pp. 4097-4104 ◽  
Author(s):  
Sifan Yu ◽  
Tianxiao Xu ◽  
Jie Dai ◽  
Meng Ma ◽  
Huan Tang ◽  
...  
Keyword(s):  
Interferon Alpha ◽  
High Dose ◽  
Acral Melanoma ◽  
Interferon Alpha 2B ◽  
High Dose Interferon
Sign in / Sign up

Export Citation Format

Share Document